Transparent and ethical business practices

Our support provided to healthcare professionals and organisations is governed by industry and company regulations.

As a member of Medicines Australia (MA), Roche’s pharmaceutical division abides by the MA Code of Conduct, including the transparent disclosure of reportable payments to healthcare professionals for provision of expert services (e.g. giving a lecture, chairing an educational meeting, providing advice as part of an Advisory Board); or sponsorship to attend medical education events.

For more information about the MA Code and reporting requirements, visit the MA website.

Healthcare professionals listed in Roche’s reports can request further information from [email protected].

Download a transfe of value report

1 May 2020 - 31 October 2020 PDF CSV
1 November 2019 - 30 April 2020
1 November 2018 - 30 April 2019
1 May 2018 - 31 October 2018 PDF CSV
1 November 2017 - 30 April 2018 PDF CSV

Third Party Sponsorship

1 May 2020 - 31 October 2020
1 November 2019 - 30 April 2020


Reportable payments made to healthcare professionals are detailed in six-monthly reports, in accordance with MA Code requirements and Australia’s privacy legislation. Prior to publication, each healthcare professional listed in the reports is afforded the opportunity to verify information. Data will be publicly available for three years from the date of publication. To comply with privacy obligations, reports may be amended from time to time. Any use or disclosure of data in the reports by a third party is the responsibility of that third party, who must comply with Australian privacy laws.